Hsu Jesse Yenchih, Roy Jason A, Xie Dawei, Yang Wei, Shou Haochang, Anderson Amanda Hyre, Landis J Richard, Jepson Christopher, Wolf Myles, Isakova Tamara, Rahman Mahboob, Feldman Harold I
Department of Biostatistics and Epidemiology and.
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1181-1189. doi: 10.2215/CJN.10301016. Epub 2017 Feb 27.
Survival analysis is commonly used to evaluate factors associated with time to an event of interest ( ESRD, cardiovascular disease, and mortality) among CKD populations. Time to the event of interest is typically observed only for some participants. Other participants have their event time censored because of the end of the study, death, withdrawal from the study, or some other competing event. Classic survival analysis methods, such as Cox proportional hazards regression, rely on the assumption that any censoring is independent of the event of interest. However, in most clinical settings, such as in CKD populations, this assumption is unlikely to be true. For example, participants whose follow-up time is censored because of health-related death likely would have had a shorter time to ESRD, had they not died. These types of competing events that cause dependent censoring are referred to as competing risks. Here, we first describe common circumstances in clinical renal research where competing risks operate and then review statistical approaches for dealing with competing risks. We compare two of the most popular analytical methods used in settings of competing risks: cause-specific hazards models and the Fine and Gray approach (subdistribution hazards models). We also discuss practical recommendations for analysis and interpretation of survival data that incorporate competing risks. To demonstrate each of the analytical tools, we use a study of fibroblast growth factor 23 and risks of mortality and ESRD in participants with CKD from the Chronic Renal Insufficiency Cohort Study.
生存分析常用于评估慢性肾脏病(CKD)人群中与感兴趣事件(终末期肾病、心血管疾病和死亡率)发生时间相关的因素。通常仅对部分参与者观察到感兴趣事件的发生时间。其他参与者的事件时间由于研究结束、死亡、退出研究或其他竞争事件而被删失。经典的生存分析方法,如Cox比例风险回归,依赖于任何删失都与感兴趣事件无关的假设。然而,在大多数临床环境中,如在CKD人群中,这一假设不太可能成立。例如,因与健康相关的死亡而随访时间被删失的参与者,如果他们没有死亡,可能患终末期肾病的时间会更短。这些导致依赖删失的竞争事件被称为竞争风险。在此,我们首先描述临床肾脏研究中竞争风险起作用的常见情况,然后回顾处理竞争风险的统计方法。我们比较竞争风险环境中使用的两种最流行的分析方法:特定病因风险模型和Fine and Gray方法(亚分布风险模型)。我们还讨论了纳入竞争风险的生存数据分析和解释的实用建议。为了展示每种分析工具,我们使用了一项来自慢性肾功能不全队列研究的关于成纤维细胞生长因子23与CKD参与者死亡率和终末期肾病风险的研究。